Literature DB >> 8940649

Influenza vaccination for all elderly.

G Wijma1, G J Ligthart.   

Abstract

In the elderly, incidence, morbidity, complications, and mortality due to influenza are greatly underestimated. There are several reasons why influenza vaccination is unjustly denied to many elderly. In a number of countries such as the United Kingdom and The Netherlands, health authorities do not recommend to vaccinate all elderly persons above a certain age, and influenza vaccination is offered only to those with conventional risk factors such as cardiac or pulmonary disease. However, conventional risk factors are often not present or are not recognized in the elderly. There now is convincing evidence that age in itself leads to increased vulnerability and thus is a risk factor for influenza and its complications. It no longer seems justified not to vaccinate all elderly, including the healthy, against influenza.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940649     DOI: 10.1159/000213802

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  3 in total

1.  Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects.

Authors:  R Gasparini; T Pozzi; E Montomoli; E Fragapane; F Senatore; M Minutello; A Podda
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 12.434

2.  [Viral respiratory infections as cause of fever in hospitalized aged patients during a winter season].

Authors:  V Sivier; M F Odelin; R Gonthier; B Pozzetto
Journal:  Rev Med Interne       Date:  2001-12       Impact factor: 0.728

3.  Seasonal Influenza and Low Flu Vaccination Coverage as Important Factors Modifying the Costs and Availability of Hospital Services in Poland: A Retrospective Comparative Study.

Authors:  Robert Susło; Piotr Pobrotyn; Lidia Brydak; Łukasz Rypicz; Urszula Grata-Borkowska; Jarosław Drobnik
Journal:  Int J Environ Res Public Health       Date:  2021-05-13       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.